Tsiporah B. Shore, M.D.

Medical Oncology

Tsiporah B. Shore, M.D.

Dr. Shore is an expert in stem cell / bone marrow transplantation, with over 20 years of experience in this field. She is the Associate Director of the Blood and Bone Marrow Transplant Program of New York Presbyterian Hospital - Cornell. She has major interests in improving the overall safety and effectiveness of transplantation. Dr. Shore is also very experienced in the management of hematological malignancies such as leukemia, lymphoma, myeloma, myelodysplasia, as well as aplastic anemia. Dr Shore teaches residents and fellows management of patients undergoing transplantation and has published articles in this field. She also reviews articles for medical journals relating to stem cell transplantation.

Dr. Shore is also an expert in the field of melanoma. She is a member of the New York City Melanoma Consortium, conducting clinical trials in the therapy of early and late stage melanoma.

Dr. Shore is committed to providing the best possible, state of the art care for her patients, with clear explanations and ongoing personal support through difficult situations.

Dr. Tsiporah Shore is the Associate Director of the Bone Marrow and Stem Cell Transplantation Program in the Division of Hematology / Oncology of Weill Medical College of Cornell University and New York Presbyterian Hospital. She is an Associate Professor of Clinical Medicine at Weill Medical College. Dr. Shore graduated from medical school (1979) and did a residency at the University of Manitoba in Canada and the University of Toronto ( internship.) She then went on to complete a hematology / oncology fellowship at Tufts New England Medical Center in Boston. She did an additional 2 year subspecialty fellowship in Bone Marrow Transplantation in Seattle and Vancouver and subsequently developed and directed the Manitoba BMT Program, in Winnipeg, Canada from 1987 - 1999. Dr. Shore has extensive experience in the diagnosis and management of all hematological malignancies including leukemias, lymphomas, myeloma, and myelodysplastic/ myeloproliferative disorders. Dr. Shore also has a major interest in the management of malignant melanoma. She was the provincial representative to the National Cancer Institute of Canada on the Melanoma subcommittee and both conducted and participated in clinical trials in the area of melanoma. She is now a member of the New York Melanoma Consortium. In 1999, Dr. Shore relocated to New York and eventually joined the staff of Weill Medical College of Cornell University, with her practise located at New York Presbyterian Hospital. While Dr. Shore has experience in all facets of hematology and oncology, she is especially interested in continuing to advance the field of bone marrow / stem cell transplantation, malignant hematologic disorders and melanoma utilizing novel therapies and clinical trials in addition to standard therapies.

Back to topBack To Top